Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Guidelines
  3. Guidelines by topic
  4. Endocrine and Neuroendocrine Cancers

Clinical Practice Guideline – Merkel-Cell Carcinoma

Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Published online: 30 April 2024 - ESMO Open
Lugowska I, Becker JC, Ascierto PA, et al., on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing Merkel-cell carcinoma (MCC).
    • Recommendations are based on available scientific data and the multidisciplinary group of experts’ collective opinion.
  • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
  • Algorithms for the management of locoregional and inoperable/metastatic disease are provided.
  • A multidisciplinary team (MDT) with a high level of expertise in MCC should diagnose and make decisions about therapy.

Related items

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.